凯赛生物：9月29日召开董事会会议

Company Overview - Kaisa Biotech (SH 688065) announced on September 29 that its third board meeting was held to discuss the proposal for the postponement of certain fundraising projects [1] - As of the report, Kaisa Biotech has a market capitalization of 37.2 billion yuan [1] Revenue Composition - For the year 2024, Kaisa Biotech's revenue composition is as follows: synthetic biological materials account for 95.31% and other businesses account for 4.69% [1]